10.27
Precedente Chiudi:
$10.44
Aprire:
$10.48
Volume 24 ore:
1.67M
Relative Volume:
0.91
Capitalizzazione di mercato:
$891.41M
Reddito:
-
Utile/perdita netta:
$-168.09M
Rapporto P/E:
-4.7327
EPS:
-2.17
Flusso di cassa netto:
$-138.01M
1 W Prestazione:
+5.88%
1M Prestazione:
+16.05%
6M Prestazione:
+56.55%
1 anno Prestazione:
-38.58%
Kura Oncology Inc Stock (KURA) Company Profile
Nome
Kura Oncology Inc
Settore
Industria
Telefono
(858) 500-8800
Indirizzo
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Confronta KURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
KURA
Kura Oncology Inc
|
10.27 | 906.16M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Iniziato | Guggenheim | Neutral |
| 2025-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-14 | Downgrade | Stifel | Buy → Hold |
| 2023-12-22 | Iniziato | Mizuho | Buy |
| 2023-08-11 | Iniziato | BofA Securities | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Perform |
| 2023-05-17 | Iniziato | BTIG Research | Buy |
| 2023-01-31 | Iniziato | Stifel | Buy |
| 2022-07-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-02-15 | Iniziato | Jefferies | Buy |
| 2021-05-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-11-05 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Iniziato | Credit Suisse | Outperform |
| 2020-05-05 | Iniziato | Barclays | Overweight |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2018-11-09 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-01 | Iniziato | H.C. Wainwright | Buy |
| 2016-10-13 | Ripresa | Leerink Partners | Outperform |
| 2016-01-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-30 | Iniziato | Oppenheimer | Outperform |
| 2015-12-16 | Iniziato | Citigroup | Buy |
Mostra tutto
Kura Oncology Inc Borsa (KURA) Ultime notizie
Applying sector rotation models to Kura Oncology Inc.July 2025 Movers & Safe Capital Growth Tips - newser.com
Understanding Kura Oncology Inc.’s price movement2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha
What drives Kura Oncology Inc stock priceGap Up/Gap Down Analysis & Tap Into the Fastest-Growing Companies - earlytimes.in
Signal strength of Kura Oncology Inc. stock in tech scannersPortfolio Growth Summary & Weekly Sector Rotation Insights - newser.com
How Kura Oncology Inc. stock reacts to Fed rate cutsJuly 2025 Sector Moves & Short-Term High Return Ideas - newser.com
What analysts say about Kura Oncology Inc stockGap Up/Gap Down Analysis & Follow Top Performers in the Community - earlytimes.in
Can technical indicators confirm Kura Oncology Inc.’s reversalJuly 2025 Rallies & Target Return Focused Stock Picks - newser.com
What momentum indicators show for Kura Oncology Inc. stockAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Can Kura Oncology Inc. stock resist market sell offs2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Kura Oncology (KURA) to Release Earnings on Thursday - MarketBeat
Kura Oncology Inc. stock momentum explained2025 Price Targets & Low Risk Entry Point Tips - newser.com
Candlestick signals on Kura Oncology Inc. stock todayJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
Why Kura Oncology Inc. stock attracts high net worth investorsPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Can Kura Oncology Inc. stock rebound after recent weaknessJuly 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
Is Kura Oncology Inc. showing signs of accumulation2025 Top Gainers & Trade Opportunity Analysis - newser.com
Kura Oncology’s KO-2806 Study: A New Hope for Advanced Solid Tumors? - The Globe and Mail
Kura Oncology (NASDAQ:KURA) Shares Up 9.1%Still a Buy? - MarketBeat
Kura Oncology to Report Third Quarter 2025 Financial Results - The Manila Times
Kura Oncology Inc Azioni (KURA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):